|
1
|
Ben-Moshe S and Itzkovitz S: Spatial
heterogeneity in the mammalian liver. Nat Rev Gastroenterol
Hepatol. 16:395–410. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Halpern KB, Shenhav R, Matcovitch-Natan O,
Toth B, Lemze D, Golan M, Massasa EE, Baydatch S, Landen S, Moor
AE, et al: Single-cell spatial reconstruction reveals global
division of labour in the mammalian liver. Nature. 542:352–356.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang S, Wang X, Shan Y, Tan Z, Su Y, Cao
Y, Wang S, Dong J, Gu J and Wang Y: Region-specific cellular and
molecular basis of liver regeneration after acute pericentral
injury. Cell Stem Cell. 31:341–358. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Watson BR, Paul B, Rahman RU,
Amir-Zilberstein L, Segerstolpe Å, Epstein ET, Murphy S,
Geistlinger L, Lee T, Shih A, et al: Spatial transcriptomics of
healthy and fibrotic human liver at single-cell resolution. Nat
Commun. 16:3192025. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fang T, Yang C, Qiu H, Du Y, Wang X, Li Y,
Xu M, Liu C, Li X, Guo N, et al: Conversion of transplanted mature
hepatocytes into Afp+ reprogrammed cells for liver
regeneration after injury. Adv Sci (Weinh). 13:e171262026.
View Article : Google Scholar
|
|
6
|
Gebhardt R: Metabolic zonation of the
liver: Regulation and implications for liver function. Pharmacol
Ther. 53:275–354. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Braeuning A, Ittrich C, Kohle C,
Hailfinger S, Bonin M, Buchmann A and Schwarz M: Differential gene
expression in periportal and perivenous mouse hepatocytes. FEBS J.
273:5051–5061. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jungermann K and Katz N: Functional
specialization of different hepatocyte populations. Physiol Rev.
69:708–764. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jungermann K and Katz N: Functional
hepatocellular heterogeneity. Hepatology. 2:385–395. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hijmans BS, Grefhorst A, Oosterveer MH and
Groen AK: Zonation of glucose and fatty acid metabolism in the
liver: Mechanism and metabolic consequences. Biochimie. 96:121–129.
2014. View Article : Google Scholar
|
|
11
|
Jungermann K and Kietzmann T: Zonation of
parenchymal and nonparenchymal metabolism in liver. Annu Rev Nutr.
16:179–203. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haussinger D and Gerok W: Hepatocyte
heterogeneity in ammonia metabolism: Impairment of glutamine
synthesis in CCL4 induced liver cell necrosis with no effect on
urea synthesis. Chem Biol Interact. 48:191–194. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Berndt N, Kolbe E, Gajowski R, Eckstein J,
Ott F, Meierhofer D, Holzhutter HG and Matz-Soja M: Functional
consequences of metabolic zonation in murine livers: Insights for
an old story. Hepatology. 73:795–810. 2021. View Article : Google Scholar
|
|
14
|
Zanger UM and Schwab M: Cytochrome p450
enzymes in drug metabolism: Regulation of gene expression, enzyme
activities, and impact of genetic variation. Pharmacol Ther.
138:103–141. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Parlakgul G, Arruda AP, Pang S, Cagampan
E, Min N, Guney E, Lee GY, Inouye K, Hess HF, Xu CS and
Hotamışlıgil GS: Regulation of liver subcellular architecture
controls metabolic homeostasis. Nature. 603:736–742. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Parlakgul G, Pang S, Artico LL, Min N,
Cagampan E, Villa R, Goncalves R, Lee GY, Xu CS, Hotamisligil GS
and Arruda AP: Spatial mapping of hepatic ER and mitochondria
architecture reveals zonated remodeling in fasting and obesity. Nat
Commun. 15:39822024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Plata-Gomez AB, de Prado-Rivas L, Sanz A,
Deleyto-Seldas N, Garcia F, de la Calle AC, Silva C, Caleiras E,
Grana-Castro O, Pineiro-Yanez E, et al: Hepatic nutrient and
hormone signaling to mTORC1 instructs the postnatal metabolic
zonation of the liver. Nat Commun. 15:18782024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kozuki S, Kabata M, Sakurai S, Iwaisako K,
Nishimura T, Toi M, Yamamoto T and Toyoshima F: Periportal
hepatocyte proliferation at midgestation governs maternal glucose
homeostasis in mice. Commun Biol. 6:12262023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rosenberger FA, Thielert M, Strauss MT,
Schweizer L, Ammar C, Madler SC, Metousis A, Skowronek P, Wahle M,
Madden K, et al: Spatial single-cell mass spectrometry defines
zonation of the hepatocyte proteome. Nat Methods. 20:1530–1536.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He S, Guo Z, Zhou M, Wang H, Zhang Z, Shi
M, Li X, Yang X and He L: Spatial-temporal proliferation of
hepatocytes during pregnancy revealed by genetic lineage tracing.
Cell Stem Cell. 30:1549–1558. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hildebrandt F, Andersson A, Saarenpaa S,
Larsson L, Van Hul N, Kanatani S, Masek J, Ellis E, Barragan A,
Mollbrink A, et al: Spatial transcriptomics to define
transcriptional patterns of zonation and structural components in
the mouse liver. Nat Commun. 12:70462021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liang Y, Kaneko K, Xin B, Lee J, Sun X,
Zhang K and Feng GS: Temporal analyses of postnatal liver
development and maturation by single-cell transcriptomics. Dev
Cell. 57:398–414. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang L, Wang X, Zheng JX, Xu ZR, Li LC,
Xiong YL, Zhou BC, Gao J and Xu CR: Determination of key events in
mouse hepatocyte maturation at the single-cell level. Dev Cell.
58:1996–2010. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsumoto T, Wakefield L, Tarlow BD and
Grompe M: In vivo lineage tracing of polyploid hepatocytes reveals
extensive proliferation during liver regeneration. Cell Stem Cell.
26:34–47. 2020. View Article : Google Scholar
|
|
25
|
Katsuda T, Hosaka K, Matsuzaki J, Usuba W,
Prieto-Vila M, Yamaguchi T, Tsuchiya A, Terai S and Ochiya T:
Transcriptomic dissection of hepatocyte heterogeneity: Linking
ploidy, zonation, and stem/progenitor cell characteristics. Cell
Mol Gastroenterol Hepatol. 9:161–183. 2020. View Article : Google Scholar
|
|
26
|
Richter ML, Deligiannis IK, Yin K, Danese
A, Lleshi E, Coupland P, Vallejos CA, Matchett KP, Henderson NC,
Colome-Tatche M and Martinez-Jimenez CP: Single-nucleus rna-seq2
reveals functional crosstalk between liver zonation and ploidy. Nat
Commun. 12:42642021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Su T, Yang Y, Lai S, Jeong J, Jung Y,
Mcconnell M, Utsumi T and Iwakiri Y: Single-cell transcriptomics
reveals zone-specific alterations of liver sinusoidal endothelial
cells in cirrhosis. Cell Mol Gastroenterol Hepatol. 11:1139–1161.
2021. View Article : Google Scholar
|
|
28
|
Payen VL, Lavergne A, Alevra SN, Colonval
M, Karim L, Deckers M, Najimi M, Coppieters W, Charloteaux B, Sokal
EM, et al: Single-cell RNA sequencing of human liver reveals
hepatic stellate cell heterogeneity. JHEP Rep. 3:1002782021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gola A, Dorrington MG, Speranza E, Sala C,
Shih RM, Radtke AJ, Wong HS, Baptista AP, Hernandez JM, Castellani
G, et al: Commensal-driven immune zonation of the liver promotes
host defence. Nature. 589:131–136. 2021. View Article : Google Scholar
|
|
30
|
Wu B, Shentu X, Nan H, Guo P, Hao S, Xu J,
Shangguan S, Cui L, Cen J, Deng Q, et al: A spatiotemporal atlas of
cholestatic injury and repair in mice. Nat Genet. 56:938–952. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kolbe E, Aleithe S, Rennert C, Spormann L,
Ott F, Meierhofer D, Gajowski R, Stopel C, Hoehme S, Kucken M, et
al: Mutual zonated interactions of Wnt and Hh signaling are
orchestrating the metabolism of the adult liver in mice and human.
Cell Rep. 29:4553–4567. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Matz-Soja M, Hovhannisyan A and Gebhardt
R: Hedgehog signalling pathway in adult liver: A major new player
in hepatocyte metabolism and zonation? Med Hypotheses. 80:589–594.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jungermann K and Kietzmann T: Oxygen:
Modulator of metabolic zonation and disease of the liver.
Hepatology. 31:255–260. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Semba H, Takeda N, Isagawa T, Sugiura Y,
Honda K, Wake M, Miyazawa H, Yamaguchi Y, Miura M, Jenkins DM, et
al: HIF-1α-PDK1 axis-induced active glycolysis plays an essential
role in macrophage migratory capacity. Nat Commun. 7:116352016.
View Article : Google Scholar
|
|
35
|
Rius J, Guma M, Schachtrup C, Akassoglou
K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG and Karin M:
NF-kappaB links innate immunity to the hypoxic response through
transcriptional regulation of HIF-1alpha. Nature. 453:807–811.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Scortegagna M, Ding K, Oktay Y, Gaur A,
Thurmond F, Yan LJ, Marck BT, Matsumoto AM, Shelton JM, Richardson
JA, et al: Multiple organ pathology, metabolic abnormalities and
impaired homeostasis of reactive oxygen species in Epas1−/− mice.
Nat Genet. 35:331–340. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rankin EB, Rha J, Selak MA, Unger TL,
Keith B, Liu Q and Haase VH: Hypoxia-inducible factor 2 regulates
hepatic lipid metabolism. Mol Cell Biol. 29:4527–4538. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Makino Y, Kanopka A, Wilson WJ, Tanaka H
and Poellinger L: Inhibitory pas domain protein (IPAS) is a
hypoxia-inducible splicing variant of the hypoxia-inducible
factor-3alpha locus. J Biol Chem. 277:32405–32408. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhan L, Huang C, Meng XM, Song Y, Wu XQ,
Yang Y and Li J: Hypoxia-inducible factor-1alpha in hepatic
fibrosis: A promising therapeutic target. Biochimie. 108:1–7. 2015.
View Article : Google Scholar
|
|
40
|
Aggarwal SR, Lindros KO and Palmer TN:
Glucagon stimulates phosphorylation of different peptides in
isolated periportal and perivenous hepatocytes. FEBS Lett.
377:439–443. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kinugasa A and Thurman RG: Differential
effect of glucagon on gluconeogenesis in periportal and pericentral
regions of the liver lobule. Biochem J. 236:425–430. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Saito K, Negishi M and James SE: Sexual
dimorphisms in zonal gene expression in mouse liver. Biochem
Biophys Res Commun. 436:730–735. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Goldfarb CN, Karri K, Pyatkov M and Waxman
DJ: Interplay between GH-regulated, Sex-biased liver transcriptome
and hepatic zonation revealed by single-nucleus RNA sequencing.
Endocrinology. 163:bqac0592022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Annunziato S, Sun T and Tchorz JS: The
RSPO-LGR4/5-ZNRF3/RNF43 module in liver homeostasis, regeneration,
and disease. Hepatology. 76:888–899. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun T, Annunziato S, Bergling S, Sheng C,
Orsini V, Forcella P, Pikiolek M, Kancherla V, Holwerda S, Imanci
D, et al: ZNRF3 and RNF43 cooperate to safeguard metabolic liver
zonation and hepatocyte proliferation. Cell Stem Cell.
28:1822–1837. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Torre C, Perret C and Colnot S: Molecular
determinants of liver zonation. Prog Mol Biol Transl Sci.
97:127–150. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hu S, Liu S, Bian Y, Poddar M, Singh S,
Cao C, Mcgaughey J, Bell A, Blazer LL, Adams JJ, et al: Single-cell
spatial transcriptomics reveals a dynamic control of metabolic
zonation and liver regeneration by endothelial cell Wnt2 and Wnt9b.
Cell Rep Med. 3:1007542022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Benhamouche S, Decaens T, Godard C,
Chambrey R, Rickman DS, Moinard C, Vasseur-Cognet M, Kuo CJ, Kahn
A, Perret C and Colnot S: Apc tumor suppressor gene is the
'zonation-keeper' of mouse liver. Dev Cell. 10:759–770. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gerbal-Chaloin S, Dume A, Briolotti P,
Klieber S, Raulet E, Duret C, Fabre J, Ramos J, Maurel P and
Daujat-Chavanieu M: The Wnt/β-catenin pathway is a transcriptional
regulator of CYP2E1, CYP1A2, and aryl hydrocarbon receptor gene
expression in primary human hepatocytes. Mol Pharmacol. 86:624–634.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kietzmann T: Liver zonation in health and
disease: Hypoxia and hypoxia-inducible transcription factors as
concert masters. Int J Mol Sci. 20:23472019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mazumdar J, O'Brien WT, Johnson RS,
Lamanna JC, Chavez JC, Klein PS and Simon MC: O2 regulates stem
cells through Wnt/β-catenin signalling. Nat Cell Biol.
12:1007–1013. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mori H, Yao Y, Learman BS, Kurozumi K,
Ishida J, Ramakrishnan SK, Overmyer KA, Xue X, Cawthorn WP, Reid
MA, et al: Induction of WNT11 by hypoxia and hypoxia-inducible
factor-1α regulates cell proliferation, migration and invasion. Sci
Rep. 6:215202016. View Article : Google Scholar
|
|
53
|
Braeuning A, Menzel M, Kleinschnitz EM,
Harada N, Tamai Y, Kohle C, Buchmann A and Schwarz M: Serum
components and activated Ha-ras antagonize expression of perivenous
marker genes stimulated by beta-catenin signaling in mouse
hepatocytes. FEBS J. 274:4766–4777. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mcenerney L, Duncan K, Bang BR, Elmasry S,
Li M, Miki T, Ramakrishnan SK, Shah YM and Saito T: Dual modulation
of human hepatic zonation via canonical and non-canonical Wnt
pathways. Exp Mol Med. 49:e4132017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wakizaka K, Kamiyama T, Kakisaka T, Orimo
T, Nagatsu A, Aiyama T, Shichi S and Taketomi A: Expression of
Wnt5a and ROR2, components of the noncanonical Wnt-signaling
pathway, is associated with tumor differentiation in hepatocellular
carcinoma. Ann Surg Oncol. 31:262–271. 2024. View Article : Google Scholar
|
|
56
|
Yang J, Cusimano A, Monga JK, Preziosi ME,
Pullara F, Calero G, Lang R, Yamaguchi TP, Nejak-Bowen KN and Monga
SP: Wnt5a inhibits hepatocyte proliferation and concludes
beta-catenin signaling in liver regeneration. Am J Pathol.
185:2194–2205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Omenetti A, Choi S, Michelotti G and Diehl
AM: Hedgehog signaling in the liver. J Hepatol. 54:366–373. 2011.
View Article : Google Scholar
|
|
58
|
Varnat F, Zacchetti G and Ruiz IAA:
Hedgehog pathway activity is required for the lethality and
intestinal phenotypes of mice with hyperactive Wnt signaling. Mech
Dev. 127:73–81. 2010. View Article : Google Scholar
|
|
59
|
Matz-Soja M, Aleithe S, Marbach E, Bottger
J, Arnold K, Schmidt-Heck W, Kratzsch J and Gebhardt R: Hepatic
hedgehog signaling contributes to the regulation of IGF1 and IGFBP1
serum levels. Cell Commun Signal. 12:112014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Sicklick JK, Li YX, Choi SS, Qi Y, Chen W,
Bustamante M, Huang J, Zdanowicz M, Camp T, Torbenson MS, et al:
Role for hedgehog signaling in hepatic stellate cell activation and
viability. Lab Invest. 85:1368–1380. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Saviano A, Henderson NC and Baumert TF:
Single-cell genomics and spatial transcriptomics: Discovery of
novel cell states and cellular interactions in liver physiology and
disease biology. J Hepatol. 73:1219–1230. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Rocha AS, Vidal V, Mertz M, Kendall TJ,
Charlet A, Okamoto H and Schedl A: The angiocrine factor rspondin3
is a key determinant of liver zonation. Cell Rep. 13:1757–1764.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Halpern KB, Shenhav R, Massalha H, Toth B,
Egozi A, Massasa EE, Medgalia C, David E, Giladi A, Moor AE, et al:
Paired-cell sequencing enables spatial gene expression mapping of
liver endothelial cells. Nat Biotechnol. 36:962–970. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Macparland SA, Liu JC, Ma XZ, Innes BT,
Bartczak AM, Gage BK, Manuel J, Khuu N, Echeverri J, Linares I, et
al: Single cell RNA sequencing of human liver reveals distinct
intrahepatic macrophage populations. Nat Commun. 9:43832018.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wen Y, Lambrecht J, Ju C and Tacke F:
Hepatic macrophages in liver homeostasis and diseases-diversity,
plasticity and therapeutic opportunities. Cell Mol Immunol.
18:45–56. 2021. View Article : Google Scholar
|
|
66
|
Trinh VQ, Lee TF, Lemoinne S, Ray KC,
Ybanez MD, Tsuchida T, Carter JK, Agudo J, Brown BD, Akat KM, et
al: Hepatic stellate cells maintain liver homeostasis through
paracrine neurotrophin-3 signaling that induces hepatocyte
proliferation. Sci Signal. 16:eadf66962023. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Dobie R, Wilson-Kanamori JR, Henderson B,
Smith JR, Matchett KP, Portman JR, Wallenborg K, Picelli S,
Zagorska A, Pendem SV, et al: Single-cell transcriptomics uncovers
zonation of function in the mesenchyme during liver fibrosis. Cell
Rep. 29:1832–1847. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Khan MA, Fischer J, Harrer L, Schwiering
F, Groneberg D and Friebe A: Hepatic stellate cells in zone 1
engage in capillarization rather than myofibroblast formation in
murine liver fibrosis. Sci Rep. 14:188402024. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bravo GC, Matetovici I, Hillen H, Taskiran
II, Vandepoel R, Christiaens V, Sansores-Garcia L, Verboven E,
Hulselmans G, Poovathingal S, et al: Single-cell spatial
multi-omics and deep learning dissect enhancer-driven gene
regulatory networks in liver zonation. Nat Cell Biol. 26:153–167.
2024. View Article : Google Scholar
|
|
70
|
Chen H, Lu S, Zhou J, Bai Z, Fu H, Xu X,
Yang S, Jiao B and Sun Y: An integrated approach for the
identification of USF1-centered transcriptional regulatory networks
during liver regeneration. Biochim Biophys Acta. 1839:415–423.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Brosch M, Kattler K, Herrmann A, von
Schonfels W, Nordstrom K, Seehofer D, Damm G, Becker T, Zeissig S,
Nehring S, et al: Epigenomic map of human liver reveals principles
of zonated morphogenic and metabolic control. Nat Commun.
9:41502018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Stanulovic VS, Kyrmizi I, Kruithof-De JM,
Hoogenkamp M, Vermeulen JL, Ruijter JM, Talianidis I, Hakvoort TB
and Lamers WH: Hepatic hnf4alpha deficiency induces periportal
expression of glutamine synthetase and other pericentral enzymes.
Hepatology. 45:433–444. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Lee J, Wang C, Xu S, Cho Y, Wang L, Feng
X, Baldridge A, Sartorelli V, Zhuang L, Peng W, et al: H3K4 mono-
and di-methyltransferase MLL4 is required for enhancer activation
during cell differentiation. Elife. 2:e15032013. View Article : Google Scholar
|
|
74
|
Moore A, Wu L, Chuang J, Sun X, Luo X,
Gopal P, Li L, Celen C, Zimmer M and Zhu H: Arid1a loss drives
nonalcoholic steatohepatitis in mice through epigenetic
dysregulation of hepatic lipogenesis and fatty acid oxidation.
Hepatology. 69:1931–1945. 2019. View Article : Google Scholar
|
|
75
|
Qu Y, Deng C, Luo Q, Shang X, Wu J, Shi Y,
Wang L and Han Z: Arid1a regulates insulin sensitivity and lipid
metabolism. EBioMedicine. 42:481–493. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Hsu SH, Delgado ER, Otero PA, Teng KY,
Kutay H, Meehan KM, Moroney JB, Monga JK, Hand NJ, Friedman JR, et
al: Microrna-122 regulates polyploidization in the murine liver.
Hepatology. 64:599–615. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ben-Moshe S, Shapira Y, Moor AE, Manco R,
Veg T, Bahar Halpern K and Itzkovitz S: Spatial sorting enables
comprehensive characterization of liver zonation. Nat Metab.
1:899–911. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wang B, Zhao L, Fish M, Logan CY and Nusse
R: Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of
the liver. Nature. 524:180–185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Sun T, Pikiolek M, Orsini V, Bergling S,
Holwerda S, Morelli L, Hoppe PS, Planas-Paz L, Yang Y, Ruffner H,
et al: Axin2+ pericentral hepatocytes have limited
contributions to liver homeostasis and regeneration. Cell Stem
Cell. 26:97–107.e6. 2020. View Article : Google Scholar
|
|
80
|
May S, Muller M, Livingstone CR, Skalka
GL, Walsh PJ, Nixon C, Hedley A, Shaw R, Clark W, Vande VJ, et al:
Absent expansion of AXIN2+ hepatocytes and altered physiology in
Axin2CreERT2 mice challenges the role of pericentral hepatocytes in
homeostatic liver regeneration. J Hepatol. 78:1028–1036. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lin S, Nascimento EM, Gajera CR, Chen L,
Neuhofer P, Garbuzov A, Wang S and Artandi SE: Distributed
hepatocytes expressing telomerase repopulate the liver in
homeostasis and injury. Nature. 556:244–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Ben-Moshe S, Veg T, Manco R, Dan S,
Papinutti D, Lifshitz A, Kolodziejczyk AA, Bahar HK, Elinav E and
Itzkovitz S: The spatiotemporal program of zonal liver regeneration
following acute injury. Cell Stem Cell. 29:973–989. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
He L, Pu W, Liu X, Zhang Z, Han M, Li Y,
Huang X, Han X, Li Y, Liu K, et al: Proliferation tracing reveals
regional hepatocyte generation in liver homeostasis and repair.
Science. 371:eabc43462021. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Prior N, Hindley CJ, Rost F, Melendez E,
Lau W, Gottgens B, Rulands S, Simons BD and Huch M:
Lgr5+ stem and progenitor cells reside at the apex of a
heterogeneous embryonic hepatoblast pool. Development.
146:dev1745572019. View Article : Google Scholar
|
|
85
|
Qin D, Liu S, Lu Y, Yan Y, Zhang J, Cao S,
Chen M, Chen N, Huang W, Wang L, et al: Lgr5+ cell fate
regulation by coordination of metabolic nuclear receptors during
liver repair. Theranostics. 12:6130–6142. 2022. View Article : Google Scholar
|
|
86
|
Chen F, Jimenez RJ, Sharma K, Luu HY, Hsu
BY, Ravindranathan A, Stohr BA and Willenbring H: Broad
distribution of hepatocyte proliferation in liver homeostasis and
regeneration. Cell Stem Cell. 26:27–33. 2020. View Article : Google Scholar
|
|
87
|
Wei Y, Wang YG, Jia Y, Li L, Yoon J, Zhang
S, Wang Z, Zhang Y, Zhu M, Sharma T, et al: Liver homeostasis is
maintained by midlobular zone 2 hepatocytes. Science.
371:eabb16252021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Kubota N, Kubota T and Kadowaki T:
Midlobular zone 2 hepatocytes: A gatekeeper of liver homeostasis.
Cell Metab. 33:855–856. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Lin YH, Wei Y, Zeng Q, Wang Y, Pagani CA,
Li L, Zhu M, Wang Z, Hsieh MH, Corbitt N, et al: IGFBP2 expressing
midlobular hepatocytes preferentially contribute to liver
homeostasis and regeneration. Cell Stem Cell. 30:665–676.e4. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Q BA, Vesco KK, Purnell JQ, Francisco M,
Goddard E, Guan X, Debarber A, Leo MC, Baetscher E, Rooney W, et
al: Pregnancy and weaning regulate human maternal liver size and
function. Proc Natl Acad Sci USA. 118:e21072691182021. View Article : Google Scholar
|
|
91
|
Milona A, Owen BM, van Mil S, Dormann D,
Mataki C, Boudjelal M, Cairns W, Schoonjans K, Milligan S, Parker
M, et al: The normal mechanisms of pregnancy-induced liver growth
are not maintained in mice lacking the bile acid sensor Fxr. Am J
Physiol Gastrointest Liver Physiol. 298:G151–G158. 2010. View Article : Google Scholar
|
|
92
|
Jaeschke H and Ramachandran A:
Acetaminophen hepatotoxicity: Paradigm for understanding mechanisms
of drug-induced liver injury. Ann Rev Pathol. 19:453–478. 2024.
View Article : Google Scholar
|
|
93
|
Li M, Cai S and Boyer JL: Mechanisms of
bile acid mediated inflammation in the liver. Mol Aspects Med.
56:45–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Younossi Z and Henry L: Contribution of
alcoholic and nonalcoholic fatty liver disease to the burden of
liver-related morbidity and mortality. Gastroenterology.
150:1778–1785. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ibrahim SH, Hirsova P and Gores GJ:
Non-alcoholic steatohepatitis pathogenesis: Sublethal hepatocyte
injury as a driver of liver inflammation. Gut. 67:963–972. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Chalasani N, Wilson L, Kleiner DE,
Cummings OW, Brunt EM and Unalp A: Relationship of steatosis grade
and zonal location to histological features of steatohepatitis in
adult patients with non-alcoholic fatty liver disease. J Hepatol.
48:829–834. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Sheka AC, Adeyi O, Thompson J, Hameed B,
Crawford PA and Ikramuddin S: Nonalcoholic steatohepatitis: A
review. JAMA. 323:1175–1183. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Leow WQ, Chan AW, Mendoza P, Lo R, Yap K
and Kim H: Non-alcoholic fatty liver disease: The Pathologist's
perspective. Clin Mol Hepatol. 29(Suppl): S302–S318. 2023.
View Article : Google Scholar
|
|
99
|
Carter-Kent C, Yerian LM, Brunt EM, Angulo
P, Kohli R, Ling SC, Xanthakos SA, Whitington PF,
Charatcharoenwitthaya P, Yap J, et al: Nonalcoholic steatohepatitis
in children: A multi-center clinicopathological study. Hepatology.
50:1113–1120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Swiderska-Syn M, Suzuki A, Guy CD,
Schwimmer JB, Abdelmalek MF, Lavine JE and Diehl AM: Hedgehog
pathway and pediatric nonalcoholic fatty liver disease. Hepatology.
57:1814–1825. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Machado MV, Michelotti GA, Pereira TA, Xie
G, Premont R, Cortez-Pinto H and Diehl AM: Accumulation of duct
cells with activated yap parallels fibrosis progression in
non-alcoholic fatty liver disease. J Hepatol. 63:962–970. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Gadd VL, Skoien R, Powell EE, Fagan KJ,
Winterford C, Horsfall L, Irvine K and Clouston AD: The portal
inflammatory infiltrate and ductular reaction in human nonalcoholic
fatty liver disease. Hepatology. 59:1393–1405. 2014. View Article : Google Scholar
|
|
103
|
Richardson MM, Jonsson JR, Powell EE,
Brunt EM, Neuschwander-Tetri BA, Bhathal PS, Dixon JB, Weltman MD,
Tilg H, Moschen AR, et al: Progressive fibrosis in nonalcoholic
steatohepatitis: Association with altered regeneration and a
ductular reaction. Gastroenterology. 133:80–90. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Ko S, Russell JO, Molina LM and Monga SP:
Liver progenitors and adult cell plasticity in hepatic injury and
repair: Knowns and unknowns. Annu Rev Pathol. 15:23–50. 2020.
View Article : Google Scholar
|
|
105
|
Hammoutene A and Rautou P: Role of liver
sinusoidal endothelial cells in non-alcoholic fatty liver disease.
J Hepatol. 70:1278–1291. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zhou Y, Zhao Y, Carbonaro M, Chen H,
Germino M, Adler C, Ni M, Zhu YO, Kim SY, Altarejos J, et al:
Perturbed liver gene zonation in a mouse model of non-alcoholic
steatohepatitis. Metabolism. 154:1558302024. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Kostallari E, Wei B, Sicard D, Li J,
Cooper SA, Gao J, Dehankar M, Li Y, Cao S, Yin M, et al: Stiffness
is associated with hepatic stellate cell heterogeneity during liver
fibrosis. Am J Physiol Gastrointest Liver Physiol. 322:G234–G246.
2022. View Article : Google Scholar
|
|
108
|
Llovet JM, Pinyol R, Kelley RK,
El-Khoueiry A, Reeves HL, Wang XW, Gores GJ and Villanueva A:
Molecular pathogenesis and systemic therapies for hepatocellular
carcinoma. Nat Cancer. 3:386–401. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Barker N and Clevers H: Mining the Wnt
pathway for cancer therapeutics. Nat Rev Drug Discov. 5:997–1014.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Sia D, Villanueva A, Friedman SL and
Llovet JM: Liver cancer cell of origin, molecular class, and
effects on patient prognosis. Gastroenterology. 152:745–761. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Holczbauer A, Wangensteen KJ and Shin S:
Cellular origins of regenerating liver and hepatocellular
carcinoma. JHEP Rep. 4:1004162022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Perugorria MJ, Olaizola P, Labiano I,
Esparza-Baquer A, Marzioni M, Marin J, Bujanda L and Banales JM:
Wnt-beta-catenin signalling in liver development, health and
disease. Nat Rev Gastroenterol Hepatol. 16:121–136. 2019.
View Article : Google Scholar
|
|
113
|
Zhang T, Gu J, Wang X, Lu Y, Cai K, Li H,
Nie Y, Chen X and Wang J: A novel liver zonation
phenotype-associated molecular classification of hepatocellular
carcinoma. Front Immunol. 14:11402012023. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Desert R, Rohart F, Canal F, Sicard M,
Desille M, Renaud S, Turlin B, Bellaud P, Perret C, Clement B, et
al: Human hepatocellular carcinomas with a periportal phenotype
have the lowest potential for early recurrence after curative
resection. Hepatology. 66:1502–1518. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Ng C, Piscuoglio S and Terracciano LM:
Molecular classification of hepatocellular carcinoma: The view from
metabolic zonation. Hepatology. 66:1377–1380. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Stravitz RT and Lee WM: Acute liver
failure. Lancet. 394:869–881. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Anundi I, Lahteenmaki T, Rundgren M,
Moldeus P and Lindros KO: Zonation of acetaminophen metabolism and
cytochrome P450 2E1-mediated toxicity studied in isolated
periportal and perivenous hepatocytes. Biochem Pharmacol.
45:1251–1259. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Avasarala S, Yang L, Sun Y, Leung AW, Chan
W, Cheung W and Lee SS: A temporal study on the histopathological,
biochemical and molecular responses of CCL(4)-induced
hepatotoxicity in Cyp2e1-null mice. Toxicology. 228:310–322. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Matchett KP, Wilson-Kanamori JR, Portman
JR, Kapourani CA, Fercoq F, May S, Zajdel E, Beltran M, Sutherland
EF, Mackey J, et al: Multimodal decoding of human liver
regeneration. Nature. 630:158–165. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Kpetemey M, Dasgupta S, Rajendiran S, Das
S, Gibbs LD, Shetty P, Gryczynski Z and Vishwanatha JK: MIEN1, a
novel interactor of annexin A2, promotes tumor cell migration by
enhancing AnxA2 cell surface expression. Mol Cancer. 14:1562015.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Gouw ASH, Clouston AD and Theise ND:
Ductular reactions in human liver: Diversity at the interface.
Hepatology. 54:1853–1863. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Miyajima A, Tanaka M and Itoh T:
Stem/progenitor cells in liver development, homeostasis,
regeneration, and reprogramming. Cell Stem Cell. 14:561–574. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Fickert P, Stoger U, Fuchsbichler A,
Moustafa T, Marschall HU, Weiglein AH, Tsybrovskyy O, Jaeschke H,
Zatloukal K, Denk H and Trauner M: A new xenobiotic-induced mouse
model of sclerosing cholangitis and biliary fibrosis. Am J Pathol.
171:525–536. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Kullak-Ublick GA, Stieger B and Meier PJ:
Enterohepatic bile salt transporters in normal physiology and liver
disease. Gastroenterology. 126:322–342. 2004. View Article : Google Scholar
|
|
125
|
Font-Burgada J, Shalapour S, Ramaswamy S,
Hsueh B, Rossell D, Umemura A, Taniguchi K, Nakagawa H, Valasek MA,
Ye L, et al: Hybrid periportal hepatocytes regenerate the injured
liver without giving rise to cancer. Cell. 162:766–779. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Shao C, Jing Y, Zhao S, Yang X, Hu Y, Meng
Y, Huang Y, Ye F, Gao L, Liu W, et al: LPS/Bcl3/YAP1 signaling
promotes Sox9+HNF4α+ hepatocyte-mediated liver regeneration after
hepatectomy. Cell Death Dis. 13:2772022. View Article : Google Scholar
|
|
127
|
Gribben C, Galanakis V, Calderwood A,
Williams EC, Chazarra-Gil R, Larraz M, Frau C, Puengel T, Guillot
A, Rouhani FJ, et al: Acquisition of epithelial plasticity in human
chronic liver disease. Nature. 630:166–173. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Lu W, Bird TG, Boulter L, Tsuchiya A, Cole
AM, Hay T, Guest RV, Wojtacha D, Man TY, Mackinnon A, et al:
Hepatic progenitor cells of biliary origin with liver repopulation
capacity. Nat Cell Biol. 17:971–983. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Pu W, Zhang H, Huang X, Tian X, He L, Wang
Y, Zhang L, Liu Q, Li Y, Li Y, et al: Mfsd2a+ hepatocytes
repopulate the liver during injury and regeneration. Nat Commun.
7:133692016. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Tarlow BD, Finegold MJ and Grompe M:
Clonal tracing of Sox9+ liver progenitors in mouse oval cell
injury. Hepatology. 60:278–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Tarlow BD, Pelz C, Naugler WE, Wakefield
L, Wilson EM, Finegold MJ and Grompe M: Bipotential adult liver
progenitors are derived from chronically injured mature
hepatocytes. Cell Stem Cell. 15:605–618. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Raven A, Lu WY, Man TY, Ferreira-Gonzalez
S, O'Duibhir E, Dwyer BJ, Thomson JP, Meehan RR, Bogorad R,
Koteliansky V, et al: Cholangiocytes act as facultative liver stem
cells during impaired hepatocyte regeneration. Nature. 547:350–354.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Pradhan-Sundd T, Kosar K, Saggi H, Zhang
R, Vats R, Cornuet P, Green S, Singh S, Zeng G, Sundd P, et al:
Wnt/β-catenin signaling plays a protective role in the Mdr2
knockout murine model of cholestatic liver disease. Hepatology.
71:1732–1749. 2020. View Article : Google Scholar
|
|
134
|
Macchi F and Sadler KC: Unraveling the
epigenetic basis of liver development, regeneration and disease.
Trends Genet. 36:587–597. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Caldez MJ, Van Hul N, Koh H, Teo XQ, Fan
JJ, Tan PY, Dewhurst MR, Too PG, Talib S, Chiang BE, et al:
Metabolic remodeling during liver regeneration. Dev Cell.
47:425–438.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Li W, Li L and Hui L: Cell plasticity in
liver regeneration. Trends Cell Biol. 30:329–338. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Lambrecht R, Rudolf F, Uckert A, Sladky
VC, Phan TS, Jansen J, Naim S, Kaufmann T, Keogh A, Kirschnek S, et
al: Non-canonical BIM-regulated energy metabolism determines
drug-induced liver necrosis. Cell Death Differ. 31:119–131. 2024.
View Article : Google Scholar
|
|
138
|
Gazit V, Huang J, Weymann A and Rudnick
DA: Analysis of the role of hepatic ppargamma expression during
mouse liver regeneration. Hepatology. 56:1489–1498. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Jiao M, Ren F, Zhou L, Zhang X, Zhang L,
Wen T, Wei L, Wang X, Shi H, Bai L, et al: Peroxisome
proliferator-activated receptor alpha activation attenuates the
inflammatory response to protect the liver from acute failure by
promoting the autophagy pathway. Cell Death Dis. 5:e13972014.
View Article : Google Scholar
|
|
140
|
Fan S, Gao Y, Qu A, Jiang Y, Li H, Xie G,
Yao X, Yang X, Zhu S, Yagai T, et al: YAP-TEAD mediates PPAR
α-induced hepatomegaly and liver regeneration in mice. Hepatology.
75:74–88. 2022. View Article : Google Scholar
|
|
141
|
Kaji K, Factor VM, Andersen JB, Durkin ME,
Tomokuni A, Marquardt JU, Matter MS, Hoang T, Conner EA and
Thorgeirsson SS: Dnmt1 is a required genomic regulator for murine
liver histogenesis and regeneration. Hepatology. 64:582–598. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Snykers S, Henkens T, De Rop E, Vinken M,
Fraczek J, De Kock J, De Prins E, Geerts A, Rogiers V and Vanhaecke
T: Role of epigenetics in liver-specific gene transcription,
hepatocyte differentiation and stem cell reprogrammation. J
Hepatol. 51:187–211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Shi Y, Sun H, Bao J, Zhou P, Zhang J, Li L
and Bu H: Activation of inactive hepatocytes through histone
acetylation: A mechanism for functional compensation after massive
loss of hepatocytes. Am J Pathol. 179:1138–1147. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Grimsrud PA, Carson JJ, Hebert AS, Hubler
SL, Niemi NM, Bailey DJ, Jochem A, Stapleton DS, Keller MP,
Westphall MS, et al: A quantitative map of the liver mitochondrial
phosphoproteome reveals posttranslational control of Ketogenesis.
Cell Metab. 16:672–683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Sugimoto A, Saito Y, Wang G, Sun Q, Yin C,
Lee KH, Geng Y, Rajbhandari P, Hernandez C, Steffani M, et al:
Hepatic stellate cells control liver zonation, size and functions
via R-spondin 3. Nature. 640:752–761. 2025. View Article : Google Scholar
|
|
146
|
Preziosi M, Okabe H, Poddar M, Singh S and
Monga SP: Endothelial Wnts regulate β-catenin signaling in murine
liver zonation and regeneration: A sequel to the Wnt-Wnt situation.
Hepatol Commun. 2:845–860. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Duan JL, Zhou ZY, Ruan B, Fang ZQ, Ding J,
Liu JJ, Song P, Xu H, Xu C, Yue ZS, et al: Notch-regulated
c-kit-positive liver sinusoidal endothelial cells contribute to
liver zonation and regeneration. Cell Mol Gastroenterol Hepatol.
13:1741–1756. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Li HY, Gao YX, Wu JC, Li JZ, Fu SW and Xu
MY: Single-cell transcriptome reveals a novel mechanism of
C-kit+-liver sinusoidal endothelial cells in NASH. Cell
Biosci. 14:312024. View Article : Google Scholar
|
|
149
|
Du W, Chen C, Liu Y, Quan H, Xu M, Liu J,
Song P, Fang Z, Yue Z, Xu H, et al: A combined 'eat me/don't eat
me' strategy based on exosome for acute liver injury treatment.
Cell Rep Med. 6:1020332025. View Article : Google Scholar
|
|
150
|
Rigual MDM, Angulo-Aguado M, Zagorac S,
Álvarez-Díaz R, Benítez-Mondéjar M, Yi F, Martínez-Garay C,
Santos-De-Frutos K, Kim E, Campos-Olivas R, et al: Macrophages
harness hepatocyte glutamate to boost liver regeneration. Nature.
641:1005–1016. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Hu M, Kurobe M, Jeong YJ, Fuerer C, Ghole
S, Nusse R and Sylvester KG: Wnt/beta-catenin signaling in murine
hepatic transit amplifying progenitor cells. Gastroenterology.
133:1579–1591. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Yimlamai D, Christodoulou C, Galli GG,
Yanger K, Pepe-Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ
and Camargo FD: Hippo pathway activity influences liver cell fate.
Cell. 157:1324–1338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Oh SH, Swiderska-Syn M, Jewell ML, Premont
RT and Diehl AM: Liver regeneration requires Yap1-TGFβ-dependent
epithelial-mesenchymal transition in hepatocytes. J Hepatol.
69:359–367. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Li L, Cui L, Lin P, Liu Z, Bao S, Ma X,
Nan H, Zhu W, Cen J, Mao Y, et al: Kupffer-cell-derived Ll-6 is
repurposed for hepatocyte dedifferentiation via activating
progenitor genes from injury-specific enhancers. Cell Stem Cell.
30:283–299. 2023. View Article : Google Scholar
|
|
155
|
Younossi ZM, Ratziu V, Loomba R, Rinella
M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome
PN, et al: Obeticholic acid for the treatment of non-alcoholic
steatohepatitis: Interim analysis from a multicentre, randomised,
placebo-controlled phase 3 trial. Lancet. 394:2184–2196. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Sanyal AJ, Ling L, Beuers U, Depaoli AM,
Lieu HD, Harrison SA and Hirschfield GM: Potent suppression of
hydrophobic bile acids by aldafermin, an FGF19 analogue, across
metabolic and cholestatic liver diseases. JHEP Rep. 3:1002552021.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Kimura K, Ikoma A, Shibakawa M, Shimoda S,
Harada K, Saio M, Imamura J, Osawa Y, Kimura M, Nishikawa K, et al:
Safety, tolerability, and preliminary efficacy of the anti-fibrotic
small molecule PRI-724, a CBP/β-catenin inhibitor, in patients with
Hepatitis C Virus-related cirrhosis: A single-center, open-label,
dose escalation phase 1 trial. EBioMedicine. 23:79–87. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Francque SM, Hodge A, Boursier J, Younes
ZH, Rodriguez-Araujo G, Park GS, Alkhouri N and Abdelmalek MF:
Phase 2, open-label, rollover study of cenicriviroc for liver
fibrosis associated with metabolic dysfunction-associated
steatohepatitis. Hepatol Commun. 8:e3352024. View Article : Google Scholar
|
|
159
|
Geervliet E, Karkdijk E and Bansal R:
Inhibition of intrahepatic monocyte recruitment by cenicriviroc and
extracellular matrix degradation by mmp1 synergistically attenuate
liver inflammation and fibrogenesis in vivo. Sci Rep. 14:168972024.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Lurje I, Biegel DK, Zhang IW and Tacke F:
The role of galectin-3 in liver inflammation and fibrosis. J
Inflamm Res. 19:5726372026. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Chalasani N, Abdelmalek MF, Garcia-Tsao G,
Vuppalanchi R, Alkhouri N, Rinella M, Noureddin M, Pyko M, Shiffman
M, Sanyal A, et al: Effects of belapectin, an inhibitor of
galectin-3, in patients with nonalcoholic steatohepatitis with
cirrhosis and portal hypertension. Gastroenterology. 158:1334–1345.
2020. View Article : Google Scholar
|
|
162
|
Dhir RN, Dworakowski W, Thangavel C and
Shapiro BH: Sexually dimorphic regulation of hepatic isoforms of
human cytochrome p450 by growth hormone. J Pharmacol Exp Ther.
316:87–94. 2006. View Article : Google Scholar
|
|
163
|
Matz-Soja M, Berg T and Kietzmann T:
Sex-related variations in liver homeostasis and disease: From
zonation dynamics to clinical implications. J Hepatol. 84:181–193.
2026. View Article : Google Scholar
|
|
164
|
Sinha S, Ali Q, Zhang T, T-Nguyen DH,
Hanna S, Sethiadi J, Hissong E and Schwartz RE: Aging disrupts
hepatocyte zonation homeostasis in mice and humans. Hepatology.
83:1143–1157. 2026. View Article : Google Scholar
|
|
165
|
Zhang Y, Li Z, Gou H, Song X and Zhang L:
The gut microbiota-bile acid axis: A potential therapeutic target
for liver fibrosis. Front Cell Infect Microbiol. 12:9453682022.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Rizvi F, Everton E, Smith AR, Liu H, Osota
E, Beattie M, Tam Y, Pardi N, Weissman D and Gouon-Evans V: Murine
liver repair via transient activation of regenerative pathways in
hepatocytes using lipid nanoparticle-complexed nucleoside-modified
mrna. Nat Commun. 12:6132021. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Debacker AJ, Voutila J, Catley M, Blakey D
and Habib N: Delivery of oligonucleotides to the liver with GalNAc:
From research to registered therapeutic drug. Mol Ther.
28:1759–1771. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Yang Z, Song L, Chen H, Chen Y, Xie Y and
Xie J: Exploring the potential anticancer effects of lobelia
chinensis lour in liver cancer via multiomics analysis. Med Res.
1:483–488. 2025.
|
|
169
|
Dana J, Venkatasamy A, Saviano A,
Lupberger J, Hoshida Y, Vilgrain V, Nahon P, Reinhold C, Gallix B
and Baumert TF: Conventional and artificial intelligence-based
imaging for biomarker discovery in chronic liver disease. Hepatol
Int. 16:509–522. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Ghosh S, Zhao X, Alim M, Brudno M and Bhat
M: Artificial intelligence applied to 'omics data in liver disease:
Towards a personalised approach for diagnosis, prognosis and
treatment. Gut. 74:295–311. 2025. View Article : Google Scholar
|
|
171
|
Bradley CA: Liver: Spatial division of
hepatic metabolic labour. Nat Rev Gastroenterol Hepatol.
14:1392017. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Younossi ZM, Stepanova M, Nader F, Loomba
R, Anstee QM, Ratziu V, Harrison S, Sanyal AJ, Schattenberg JM,
Barritt AS, et al: Obeticholic acid impact on quality of life in
patients with nonalcoholic steatohepatitis: REGENERATE 18-month
interim analysis. Clin Gastroenterol Hepatol. 20:2050–2058. 2022.
View Article : Google Scholar
|
|
173
|
Kessoku T, Kobayashi T, Ozaki A, Iwaki M,
Honda Y, Ogawa Y, Imajo K, Saigusa Y, Yamamoto K, Yamanaka T, et
al: Rationale and design of a randomised, double-blind,
placebo-controlled, parallel-group, investigator-initiated phase 2a
study to investigate the efficacy and safety of elobixibat in
combination with cholestyramine for non-alcoholic fatty liver
disease. BMJ Open. 10:e379612020. View Article : Google Scholar
|
|
174
|
Noureddin M, Rinella M, Taub R, Labriola
D, Camacho RC, Alkhouri N, Loomba R and Bansal MB: Effects of
resmetirom on metabolic-dysfunction associated steatohepatitis in
patients with weight loss and/or diabetes taking glucagon-like
peptide-1 receptor agonists and other diabetes therapies: A
secondary analysis of the MAESTRO-NASH trial. Aliment Pharmacol
Ther. 62:1089–1099. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Nakajima A, Eguchi Y, Yoneda M, Imajo K,
Tamaki N, Suganami H, Nojima T, Tanigawa R, Iizuka M, Iida Y, et
al: Randomised clinical trial: Pemafibrate, a novel selective
peroxisome proliferator-activated receptor alpha modulator
(SPPARMα), versus placebo in patients with non-alcoholic fatty
liver disease. Aliment Pharmacol Ther. 54:1263–1277. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Cooreman MP, Butler J, Giugliano RP,
Zannad F, Dzen L, Huot-Marchand P, Baudin M, Beard DR, Junien J,
Broqua P, et al: The pan-PPAR agonist lanifibranor improves
cardiometabolic health in patients with metabolic
dysfunction-associated steatohepatitis. Nat Commun. 15:39622024.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Cheng HS, Tan WR, Low ZS, Marvalim C, Lee
JYH and Tan NS: Exploration and development of PPAR modulators in
health and disease: An update of clinical evidence. Int J Mol Sci.
20:50552019. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Nedrud MA, Chaudhry M, Middleton MS,
Moylan CA, Lerebours R, Luo S, Farjat A, Guy C, Loomba R,
Abdelmalek MF, et al: MRI quantification of placebo effect in
nonalcoholic steatohepatitis clinical trials. Radiology.
306:e2207432023. View Article : Google Scholar
|
|
179
|
Yoo C, Fabregat-Franco C, Lin C, Qvortrup
C, Oh D, Yau T, Kim H, Castet F, Ponz Sarvise M, Hsu C, et al:
First-in-human phase 1 study of RO7119929, an oral TLR7 agonist
prodrug, in patients with advanced primary or metastatic liver
cancers. J Immunother Cancer. 14:e127832026. View Article : Google Scholar
|
